Richard M. Shepard

2.6k total citations · 1 hit paper
28 papers, 2.0k citations indexed

About

Richard M. Shepard is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Richard M. Shepard has authored 28 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Richard M. Shepard's work include Vitamin D Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Richard M. Shepard is often cited by papers focused on Vitamin D Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Richard M. Shepard collaborates with scholars based in United States. Richard M. Shepard's co-authors include George Foulds, Hector F. DeLuca, Raymond B. Johnson, Ronald L. Horst, Alan J. Hamstra, Fred C. Falkner, John A. Eisman, Jack S. Remington, Fausto G. Araujo and Michelle Mullins and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Richard M. Shepard

26 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The pharmacokinetics of azithromycin in human serum and tissues

1990 627 citations George Foulds, Richard M. Shepard et al. Journal of Antimicrobial Chemotherapy profile →

Peers

Richard M. Shepard

PFM

EPIDE

PHARM

Roberto Silva Costa Brazil

Morris Pollard United States

Veysel Tahan United States

Wilfred M. Weinstein United States

Banu Sancak Türkiye

Ian S. Menzies United Kingdom

Selwyn A. Broitman United States

Petr Dítě Czechia

В. Т. Ивашкин Russia

Seymour M. Sabesin United States

Roberto Silva Costa Brazil

Richard M. Shepard

530 ×0.9

PFM

224 ×0.4

EPIDE

181 ×0.5

PHARM

405 ×1.7

83 ×0.4

Citations per year, relative to Richard M. Shepard Richard M. Shepard (= 1×) peers Roberto Silva Costa

Countries citing papers authored by Richard M. Shepard

Since Specialization

Citations

This map shows the geographic impact of Richard M. Shepard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Shepard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Shepard more than expected).

Fields of papers citing papers by Richard M. Shepard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard M. Shepard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Shepard. The network helps show where Richard M. Shepard may publish in the future.

Co-authorship network of co-authors of Richard M. Shepard

This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Shepard. A scholar is included among the top collaborators of Richard M. Shepard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Shepard. Richard M. Shepard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gladue, Ronald P., Timothy Paradis, Carol Donovan, et al.. (2011). The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice. Cancer Immunology Immunotherapy. 60(7). 1009–1017. 55 indexed citations

Subramanyam, Chakrapani, Allen J. Duplantier, Mark A. Dombroski, et al.. (2011). Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X7 receptor. Bioorganic & Medicinal Chemistry Letters. 21(18). 5475–5479. 18 indexed citations

Gladue, Ronald P., Marsha L. Roach, Laurie Tylaska, et al.. (2006). The Human Specific CCR1 Antagonist CP-481,715 Inhibits Cell Infiltration and Inflammatory Responses in Human CCR1 Transgenic Mice. The Journal of Immunology. 176(5). 3141–3148. 33 indexed citations

Shepard, Richard M.. (2005). Nutrient management planning: Is it the answer to better management?. Journal of Soil and Water Conservation. 60(4). 171–176. 15 indexed citations

Gladue, Ronald P., Laurie Tylaska, William H. Brissette, et al.. (2003). CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases. Journal of Biological Chemistry. 278(42). 40473–40480. 59 indexed citations

Aleo, Michael D., et al.. (2000). The Use of Explant Lens Culture to Assess Cataractogenic Potential. Annals of the New York Academy of Sciences. 919(1). 171–187. 8 indexed citations

Shepard, Richard M., et al.. (1996). Preclinical Toxicology Studies with Azithromycin. Acute and Subchronic Studies in Rodents.. Medical Entomology and Zoology. 51(2). 53–63. 1 indexed citations

Milisen, William B., et al.. (1996). Preclinical toxicology studies in beagle dogs with azithromycin. 51(2). 65–74. 1 indexed citations

Koch, Kevin M., M F Newborg, Douglas C. Hanson, et al.. (1995). The C-32 Triacetyl-L-rhamnose Derivative of Ascomycin: A Potent, Orally Active Macrolactone Immunosuppressant. Journal of Medicinal Chemistry. 38(8). 1255–1258. 3 indexed citations

10.

Hoover, Dennis J., Bruce A. Lefker, Robert L. Rosati, et al.. (1995). Discovery of Inhibitors of Human Renin with High Oral Bioavailability. Advances in experimental medicine and biology. 362. 167–180. 11 indexed citations

11.

Foulds, George, et al.. (1991). Concentration of azithromycin in human prostatic tissue. European Journal of Clinical Microbiology & Infectious Diseases. 10(10). 868–871. 27 indexed citations

12.

Araujo, Fausto G., Richard M. Shepard, & Jack S. Remington. (1991). In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin againstToxoplasma gondii. European Journal of Clinical Microbiology & Infectious Diseases. 10(6). 519–524. 80 indexed citations

13.

Shepard, Richard M., et al.. (1991). High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. Journal of Chromatography B Biomedical Sciences and Applications. 565(1-2). 321–337. 88 indexed citations

14.

Foulds, George, Kenny H. Chan, Jonas T. Johnson, Richard M. Shepard, & Raymond B. Johnson. (1991). Concentrations of azithromycin in human tonsillar tissue. European Journal of Clinical Microbiology & Infectious Diseases. 10(10). 853–856. 35 indexed citations

15.

Shepard, Richard M. & Fred C. Falkner. (1990). Pharmacokinetics of azithromycin in rats and dogs. Journal of Antimicrobial Chemotherapy. 25(suppl A). 49–60. 118 indexed citations

16.

Foulds, George, Richard M. Shepard, & Raymond B. Johnson. (1990). The pharmacokinetics of azithromycin in human serum and tissues. Journal of Antimicrobial Chemotherapy. 25(suppl A). 73–82. 627 indexed citations breakdown →

17.

Shepard, Richard M.. (1981). Pharmacokinetics of Levonantradol in Laboratory Animals and Man. The Journal of Clinical Pharmacology. 21(S1). 190S–200S. 2 indexed citations

18.

Shepard, Richard M. & Hector F. DeLuca. (1980). Plasma concentrations of vitamin D3 and its metabolites in the rat as influenced by vitamin D3 or 25-hydroxyvitamin D3 intakes. Archives of Biochemistry and Biophysics. 202(1). 43–53. 117 indexed citations

19.

Eisman, John A., Richard M. Shepard, & Hector F. DeLuca. (1977). Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. Analytical Biochemistry. 80(1). 298–305. 157 indexed citations

20.

Shepard, Richard M., et al.. (1951). Complications of Pneumothorax and Pneumonolysis * *Department of Surgery, Louisiana State University School of Medicine, and Charity Hospital of New Orleans, Louisiana.. Diseases of the Chest. 19(1). 78–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact